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ABSTRACT
Grant, Delaney C. M.S. Department of Neuroscience, Cell Biology and Physiology,
Wright State University, 2021. A Novel Method for Analysis of Proprioceptor Sensory
Neuron Subtypes in the Mouse Dorsal Root Ganglia.

Proprioceptive sensory neurons encode critical mechanosensory information that helps
determine how the body interacts with the outside world and monitors the proper
execution of motor movements. Housed in skeletal muscles lie specialized
mechanoreceptors that are critical to this feedback loop: muscle spindles supplied by
group Ia & group II afferents, and Golgi tendon organs supplied by group Ib afferents
relay information regarding changes in muscle force, length, and tension. All three
afferent subtypes originate in the muscle and travel to the dorsal root ganglia, relaying
information to the central nervous system. GTO and MS proprioceptive afferent subtypes
have been identified, traced, and labeled by restrictive RNA and DNA sequencing
techniques that eliminate the potential for in vivo and ex vivo analysis. To confirm the
identity of different proprioceptive afferent subtypes in the dorsal root ganglia of mice,
the present study developed a method of fluorescence tracing using a dextran dye to trace
afferents and their origins. By injecting tetramethylrhodamine dextran dye directly into
the quadriceps muscle, the muscle spindle proprioceptive afferents selectively transport
the dye to the cell body in the DRG demonstrating its origin and classification. Being
able to selectively label and trace muscle spindle afferents allows us to accurately collect
data on the cells in the DRGs.
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I.

Introduction

Proprioception
One of the most crucial aspects of human survival is interacting with and
moving around the environment. An integral part of this function is the
proprioceptive sense, an entity’s perception of the body’s movements and
orientation in 3D space. Nerves travel from the neuromuscular junction to the
spinal cord and inform the central nervous systems of all muscle movements.
This information is interpreted by the cerebrum and confirms the execution of
motor tasks and muscle movements. Understanding this complex circuit
allows for the development of treatments for diseases and injuries affecting
proprioception, like recovery after peripheral nerve injury.
Proprioceptive feedback is dependent mainly on specialized
mechanoreceptive organs in the skeletal muscle. These proprioceptive
afferents relay critical feedback to the central nervous system regarding the
successful completion of motor tasks. Sensory afferents from the skin, muscle,
and joints provide necessary information regarding alterations in muscle
length, force, stretch, and joint angles to the spinal cord and central nervous
system (Sherrington, 1907; Windhorst, 2007). Proprioceptive sensory
neurons (pSNs) are comprised of specialized mechanoreceptors that originate
in skeletal muscles and project their cell bodies to the dorsal root ganglia
(DRG) beside the spinal cord, connecting to the central nervous system
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(Matthews, 1964). Extensive physiological studies have identified two distinct
mechanoreceptor subtypes: muscle spindles (MSs) supplied by group Ia and
group II afferents and Golgi tendon organs (GTOs) supplied by group Ib
afferents (Matthews, 1964; Schoultz and J.E., 1972; Granit, 1975).
Information from both MS and GTO afferents is relayed to higher brain
centers via projections through the dorsal spinocerebellar tract (DSCT) and
ventral spinocerebellar tract (VSCT) (Oscarsson, 1965; Shrestha et al., 2012).
Together these proprioceptive sensory neuron inputs are responsible for
conveying information pertaining to the state of muscle activation and
movement to the central nervous system, mainly through monosynaptic
connections with specific motor neurons (Baldissera et al., 1981; Poliak et al.,
2016).
Muscle Spindle Afferents
The muscle spindle has been an area of interest for over a century,
originating when Sherrington first categorized the muscle spindle as a sense
organ (Sherrington, 1884). Muscle spindle (MS) mechanoreceptors are
hyaluronic acid-filled capsules embedded in the belly of skeletal muscles and
in parallel with extrafusal muscle fibers (De-doncker et al., 2003; Banks,
2005). MS afferents are approximately 6-10mm long and structurally
complex, consisting of a bundle of intrafusal muscle fibers of several different
types (bag 1, bag 2, and chain fibers) surrounded by a capsule (Matthews,
2

1964; Banks et al., 1982; Hunt and Louis, 1990). Each muscle fiber has an
equatorial region devoid of myofibrils and containing nuclei with two
contractile poles (De-doncker et al., 2003). The largest muscle fibers, nuclear
bag fibers 1 and 2, have a significant accumulation of nuclei in the equatorial
region of the sarcomeric structure and are approximately 20-25 μm in
diameter (Hunt and Louis, 1990). Nuclear bag fiber 1 and nuclear bag fiber 2
are distinguished by their histochemical attributes, and the bag 1 fiber is
usually slightly longer than the bag 2 fiber (Hunt and Louis, 1990). Nuclear
chain fibers are approximately 10-12 μm in diameter (De-doncker et al., 2003)
and are usually much shorter than nuclear bag fibers (Hunt and Louis, 1990).
They typically run the entire length of the spindle and show a collection of
nuclei in linear formation in the fiber’s equatorial region (Hunt and Louis,
1990).
These encapsulated intrafusal muscle fibers are innervated by one primary
(group Ia axons), several secondary (group II axons) afferents, and gamma
motor neuron axons. (Matthews, 1964; Banks et al., 1982; Sonner et al.,
2017). The primary ending is the largest sensory axon to the muscle spindle
and contacts each intrafusal muscle fiber, and also displays extensive
annulospiral terminations in their nucleated regions (Boyd, 1962; Hunt and
Louis, 1990). In contrast, the smaller group II afferents primarily contact
intrafusal chain fibers and have flower-spray endings (Boyd, 1962; Banks et
3

al., 1982; Hunt and Louis, 1990; Sonner et al., 2017). While both primary and
secondary endings respond to stretch, their distinct endings encode stimuli
differently.
During a ramp-and-hold stretch, Ia afferents and II afferents exhibit
different firing responses (Crowe and Matthews, 1964). Most notably, during
ramp stretch, Ia afferents exhibit firing frequencies that depend upon the
velocity of the stretch that is higher than at the static level and paused during
the stretch release (Hunt and Louis, 1990; De-doncker et al., 2003). Group II
afferents show little dynamic responses during ramp stretch, but instead
exhibit linear responses with muscle length and responses gradually increase
to static level (Hunt and Louis, 1990; De-doncker et al., 2003). Additionally,
group Ia afferents showed a higher sensitivity to vibration frequencies than
group II afferents (De-doncker et al., 2003). As a result, group II afferents
encode static stretch and group Ia afferents encode information regarding the
dynamic stretch, also known as changes in velocity (Matthews, 1981).
Golgi Tendon Organ Afferents
Like the muscle spindle, Golgi tendon organs (GTOs) are specialized
mechanoreceptors critical to the successful execution of motor tasks. Golgi
tendon organs (GTOs), supplied by group Ib afferents, are encapsulated
stretch-activated proprioceptive sensory afferents found in the skeletal muscle
that respond to change in muscle load and tension (Schoultz and J.E., 1972;
4

Jami, 1992). One main difference between the two structures is the GTO
afferents reside in the myotendinous junction of the skeletal muscle and
respond to distinctly different stimuli (muscle load and tension) (Scott, 2005).
GTO afferents are encapsulated sensory nerve endings positioned in series
with extrafusal muscle fibers that they innervate, allowing them to be highly
sensitive to rapid changes in contractile force while responding little to stretch
(Houk and Henneman, 1967; Davies et al., 1995). Typically, a GTO is
supplied by a single large-diameter myelinated Ib afferent, which has
extensive branches and is closely associated with collagen strands (Schoultz
and J.E., 1972). Though GTO and MS afferents are integral parts of the
proprioceptive sense, they are distinct structures with various physiological
properties and functions.
Development and Reinnervation
While proprioceptive sensory neurons’ physiology and their targets are
well understood, comprehending their development and reinnervation after an
injury has evolved significantly in recent years. MS and GTO afferents
selectively innervate their central and peripheral targets, but proprioceptor
physiology can be altered after peripheral nerve injury (PNI). Problems with
recovery after PNI can result in poor motor control and sensation (Verdu and
Navarro, 1997). Understanding the underlying methods of proprioceptor
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reinnervation is essential to develop improved therapies to aid in recovery
after PNI.
During normal proprioceptive nerve development, proprioceptor sensory
neuron progenitors are born from day e9.5 to day e10 in the first wave of
DRG sensory neurogenesis and are initially segregated into two distinct
genetic lineages: TrkB+Shox2+ and TrkC+Rx3+ (Ma et al., 1999; Kramer et
al., 2006; Lallemend and Ernfors, 2012; Wu et al., 2019). Rapidly adapting
low threshold mechanoreceptors (RA-LTMRs) develop from TrkB+Shox2+
progenitor cells (Abdo et al., 2011; Li et al., 2011), while the TrkC+Rx3+
lineage gives rise to slowly adapting low threshold mechanoreceptors (SALTMRs) and to proprioceptive muscle afferents (de Nooij et al., 2013; Wu et
al., 2019). Around day e14.5, proprioceptive sensory afferents mark their
commitment to the pSN lineage by expression of parvalbumin (PV)
(Tourtellotte and Milbrandt, 1998; Hippenmeyer et al., 2002; Wu et al., 2019).
It has been shown that proprioceptor subtypes development depends upon
extrinsic sensory receptor organ-derived signals (Wu et al., 2019) and intrinsic
inductive signals for innervating sensory axons (Hippenmeyer et al., 2002).
After PNI, regenerating neurons express post-injury gene programs, including
the expression of embryonic and developmental genes, both of which
contribute to axonal regrowth and regeneration (Blackmore, 2012; Hilton and
Bradke, 2017).
6

After PNI, axons in peripheral nerves maintain the capacity to regenerate
and reinnervate, providing potential for functional recovery and improved
prognosis (Verdu and Navarro, 1997; Chandran et al., 2016). Functional
recovery after PNI entails regrowth of injured axons and reinnervation of the
muscle and target tissues, but this process is often incomplete due to
complications (Barker et al., 1985; He and Jin, 2016; Renthal et al., 2020).
The ability of axons to regrow and reinnervate properly depends upon the type
and severity of the injury. Two main models of PNI in rodent models are
sciatic nerve crush and sciatic nerve transection, and both have wellestablished reinnervation and regrowth time courses (Brown and Butler, 1976;
Collins et al., 1986; Dun and Parkinson, 2018). However, various
complications and post-injury alterations impact the proprioceptive sensory
neuron’s ability to reinnervate their target muscle and resume normal
physiological functions.
Approximately 50% of proprioceptive afferents fail to reconnect and
reinnervate the correct muscle spindles after peripheral nerve injury,
specifically in transection injuries (Banks et al., 1982). Also, proprioceptive
afferents exhibit abnormal or decreased firing rates in response to muscle
manipulation (Collins et al., 1986). Additional challenges in PNI recovery
include morphological alteration to proprioceptive sensory neuron afferents
and non-specific reinnervation of target tissues. Following reinnervation of
7

muscle spindles after nerve crush, some group Ia afferents were shorter than
normal and exhibited fewer transverse bands, and some group II afferents
showed signs of growth through the primary ending region (Collins et al.,
1986). While the majority of sensory axons reinnervate the correct target
tissue after PNI, there is evidence that regenerating proprioceptive afferents
may misconnect to the wrong target tissue (Banks et al., 1982). In-depth
investigation of pSN reinnervation and regeneration is limited by the ability to
selectively identify and isolate subtype-specific pSN afferents, particularly
MS afferents from GTO afferents. Distinguishing between MS and GTO
afferents, specifically at the DRG level, allows for confirmation of subtype
identity while investigating gene expression during development and after
injury.
Labeling and Identification
Currently, the main method of classifying and distinguishing subtypespecific afferents has relied on various genetic strategies (Wu et al., 2019;
Oliver et al., 2021). RNA sequencing technology allows for the identification
of molecularly distinct neuronal clusters and gene expression profiling (Wu et
al., 2019; Oliver et al., 2021). While this technology allows for specific
distinction between neuronal subtypes, RNA sequencing is not applicable to
living preparations used during electrophysiological experiments. Previous
studies have used retrograde tracers to track axons and presynaptic structures
8

and map out projection patterns of neurons (Kamiyama et al., 2015; Odagaki
et al., 2018). Intracutaneous injection of Alexa488-conjugated (and 549conjugated CTB) has shown to be effective at labeling cutaneous afferent
projections from the forelimbs of mice to the dorsal horn of the spinal cord
(Odagaki et al., 2018). In vivo injection of a retrograde tracer (green
fluorescent latex microspheres) has successfully labeled brain and spinal cord
tissue without fading or diffusion, permitting the analysis of spinal circuits
during development (Katz et al., 1984; Katz and Iarovici, 1990; Kamiyama et
al., 2015).
While there are various studies that utilize retrograde tracers in brain
tissue and spinal tissue, there is a lack of knowledge surrounding the
application of retrograde tracers in muscle to label neurons in the DRG (Katz
et al., 1984; Katz and Iarovici, 1990; Blumer et al., 2003; Odagaki et al.,
2018). The technique employed in this project utilized a dextran dye,
tetramethylrhodamine (rhodamine), and injected it directly into the rectus
femoris (quadriceps) muscle of mice. This project rests on the hypothesis that
injecting rhodamine dye into the muscle selectively labels muscle spindle
afferents due to their location in the belly of the muscle, where the dye is
transported to the cell bodies in the corresponding DRGs; conversely, Golgi
tendon organ afferents are not labeled due to their location at the
myotendinous junctions. To confirm the selective uptake of rhodamine dye by
9

muscle spindles, DRGs were sectioned and stained to confirm the presence of
double labeled cells. While the results of this experiment are preliminary, the
procedure and method of selectively labeling MS afferents in the DRG has
many applications. For example, it could be used to confirm the proprioceptor
subtype during reinnervation and after PNI.
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II.

Materials and Methods

Animals
All animal experiments were approved by the Wright State University
Institutional Animal Care and Use Committee and conducted following the
guidelines set by the National Institute of Health. Wild-type mice (C57BL/6J)
were used for all experiments.
Mice that did not undergo surgery were used for the ex vivo rhodamine
muscle injection experiments and the ex vivo sciatic nerve backfill
experiments. Three mice aged P4 to P10 were used for the ex vivo rhodamine
muscle injection experiments (labeled mouse 1, mouse 2, and mouse 3), and
four mice aged P5 to P7 were used for the ex vivo sciatic nerve backfill
experiments (labeled mouse 1, mouse 2, mouse 3, and mouse 4). Two mice,
one male (mouse 6A) and one female (mouse 6B), aged P23, were used for
the in vivo rhodamine muscle injection experiments. These mice underwent
surgery as described below. All procedures were conducted in accordance
with Wright State University Institutional Animal Care and Use Committee.
After 24 hours, mouse 6B was euthanized via 0.03 mL intraperitoneal
injection of Euthasol and dissected as described below. Mouse 6A was
euthanized after 48 hours via 0.03 mL intraperitoneal injection of Euthasol
and dissected as described below.
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Tissue Preparation
Mice were anesthetized using an intraperitoneal Euthasol injection (older
than P7) or by induction of hypothermia (younger than P7). In a dissecting
chamber, mice were transcardially perfused with 5mL of ice-cold oxygenated
(5% CO2; 95% O2) artificial cerebrospinal fluid (ACSF) containing 127 mM
NaCl, 1.9 mM KCL, 1.2 mM KH2PO4, 1 mM MgSO47H2O, 26 mM NaHCO3,
2 mM CaCl2, and 16.9 mM D(+)-glucose monohydrate. Animals were then
decapitated, and the vertebral column (from T1) was isolated along with the
hips and legs. Dissections were performed in a dissecting dish with the animal
preparation fully submerged in a bath of circulating cold ACSF. After the
procedures were performed, as described below, animal tissue was fixed with
4% cold paraformaldehyde (PFA) solution for 24 hours. Animal preparation
was then washed with 1X Phosphate buffer solution (PBS) twice and
equilibrated with 30% sucrose solution (in PBS) for 24 hours for
cryoprotection. Animal preparation is dissected to isolate the structure of
interest (DRGs or muscles), and structures are individually embedded in
Tissue Tek O.C.T. compound and frozen at -80˚C. Using a cryostat (ThermoFisher Scientific), tissue was sectioned in 20 μm increments and transferred to
Fisherbrand Superfrost Plus Microscope Slides. Immunohistochemistry was
performed on every fifth section, as described below.
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A. Ex Vivo Rhodamine Muscle Injection
After mice were euthanized, transcardially perfused, and transferred to
an ACSF bath, as previously described, the right and left femoral nerve
and quadriceps muscles were identified and isolated.
Tetramethylrhodamine dye was injected parallel to the direction of the
muscle fibers and into the right and left rectus femoris via a glass
micropipette. After 12 hours of remaining in the dissection dish with
circulating room temperature ACSF, the animal preparation was fixed
with 4% PFA as described above. Animal preparation was washed with
PBS, equilibrated with 30% sucrose, embedded, frozen, and sectioned as
described above. Before embedding, the right and left rectus femoris
muscles are isolated. To ensure the inclusion of Golgi tendon organ
afferents, which are located in the tendons connected to the muscle, the
patella distal to the rectus femoris is included in the tissue sample
embedded. After sectioning, immunohistochemistry was performed on
every fifth section, and slides were coverslipped using Vectashield
mounting medium to preserve fluorescence signals prior to imaging and
coverslips were added for image analysis.
B. Ex Vivo Sciatic Nerve Backfills
Mice aged P5 to P7 were used for the sciatic nerve backfill
experiments. Starting at approximately T1, the spinal cord was exposed by
13

performing a dorsal laminectomy, and the dura was removed to allow for
better circulation of ACSF to the DRGs. Excess dorsal muscles were
dissected, and preparation was flipped to the ventral side, and extra
abdominal trunk muscles were removed. The left leg was removed, and on
the dorsal side, the posterior biceps semi tendinosis (PBST) nerve is
transected, and additional muscle superficial muscles were removed. The
sural, peroneal, and tibial nerves were identified and cut, and the hipbone
was removed to expose the sciatic nerve. To achieve better oxygenation of
the spinal cord and DRG’s, the thoracic portion of the spinal cord was
dissected from the vertebral column. The femur and tibia/fibula were
removed to expose the sciatic nerve fully.
A glass micropipette was pulled, fire-polished to fit the sciatic nerve
diameter to ensure a proper suction fit. The sciatic nerve was cut, and the
glass micropipette was fitted around the end of the sciatic nerve using a
micromanipulator. The micropipette was loaded with
tetramethylrhodamine dye (approximately 1.5 μL). After 12 hours of
remaining in the dissection dish with circulating room temperature ACSF,
the animal preparation was fixed, washed with PBS, and equilibrated with
30% sucrose as previously described.
Animal preparation was further dissected to isolate the target DRG’s
(L4, L5, and L6). The vertebral column was transected superior to the L4
14

DRG and inferior to L6. To easily quickly the labeled side, the L6 DRG
was removed from the unlabeled side. The spinal column was embedded
and frozen before sectioning. After sectioning, immunohistochemistry was
performed as described below, and slides were coverslipped using
Vectashield mounting medium to preserve fluorescence signals prior to
imaging and coverslips were added for image analysis.
C. In Vivo Rhodamine Muscle Injections
One male and one female mouse, both P21, were anesthetized using
isoflurane (3.4-5%) in a chamber and subsequently transferred to a sterile
drape where a nose cone was fitted over the animal’s head to administer
the isoflurane continuously. With sterile instruments, a 3-4 mm incision in
the upper right thigh on each mouse’s ventral side was made to gain
access to the rectus femoris muscle. The incision was extended through
the fascia, and through this incision, tetramethylrhodamine (rhodamine)
dye was injected into the rectus femoris muscle using a glass micropipette
and the assistance of a microscope. The micropipette was positioned so
that the micropipette needle was parallel to the muscle fibers in the rectus
femoris muscle and on the distal end of the muscle. Approximately 2 to 3
injections were administered to allow the rectus femoris muscle to be
completely and evenly labeled. The incision was closed using 6-0 USP
silk sutures, and an analgesic was applied to the incision site.
15

Mouse 6B and 6A followed the same protocols, except mouse 6B was
euthanized after 24 hours of survival, and mouse 6A was euthanized after
48 hours of survival. Mice were euthanized via an intraperitoneal
injection of 0.03 mL Euthisol and transcardially with 5mL cold 1X PBS,
and subsequently, through the same injection site, 10mL of cold 4% PFA
was perfused. The spinal cord and legs were isolated as described before.
A dorsal laminectomy was performed to allow for better access to the
spinal cord and circulation of ACSF to the DRGs, and the dura was
removed. The animal preparation was then fixed in 4% PFS, washed with
PBS, and equilibrated with 30% sucrose as described previously. The L4,
L5, and L6 DRGs were isolated by transecting superior to the L4 vertebrae
and inferior to the L6 vertebrae before embedding. Only the right
quadriceps muscles were embedded since it was the target of the
injections. After embedding in Tissue Tek O.C.T. compound in a Peel-AWay chamber, the tissue was frozen and cut at 20 μm as previously
described.
Immunohistochemistry
Immunohistochemistry was performed on 20 μm sections. All slides were
washed three times with 1X PBS for 5 minutes each time. Slides were
incubated in a primary antibody solution (1X PBS solution with 1% bovine
serum albumin and 0.3% Triton X-100) overnight at 4˚C.
16

Primary antibodies used differed depending on the tissue being stained.
For muscle tissue, primary antibodies included guinea pig anti- vGLUT1
polyclonal antibody diluted 1:10,000 (Chemicon AB5905, Lot LV1567574)
and rabbit anti-tetramethylrhodamine polyclonal antibody diluted 1:5,000
(Life Tech A6397, Lot 1476653). Primary antibodies used for the analysis of
the DRGs included rabbit anti tetramethylrhodamine polyclonal antibody
diluted 1:5,000 (Life Tech A6397, Lot 1476653) and goat anti parvalbumin
polyclonal antibody diluted 1:10,000 (Swant PVG-214 Lot 3.6).
The next day slides were washed 3 times with 1X PBS for 5 minutes each.
Slides were incubated in a secondary antibody solution (1X PBS solution with
1% bovine serum albumin and 0.3% Triton X-100) for 45 minutes at 22˚C.
Secondary antibodies varied depending on the tissue. For muscle tissue,
antibodies used were donkey anti guinea pig Alexa 488 polyclonal antibody
diluted 1:500 (Jackson IR J 706-545-148, Lot 118980) and donkey anti-rabbit
Cy3 polyclonal antibody diluted 1:500 (Jackson IR J 711-165-152, Lot
120991). For DRG tissue, secondary antibodies included donkey anti-goat
Alexa488 polyclonal antibody diluted 1:500 (Invitrogen A11055), and donkey
anti-rabbit Cy3 polyclonal antibody diluted 1:500 (Jackson IR J 711-165-152,
Lot 120991). Following the secondary antibody solution’s incubation, the
slides were washed 3 times with 1X PBS for 5 minutes each. Slides were
coverslipped using Vectashield mounting medium to preserve fluorescence
17

signals prior to imaging and coverslips were added for image analysis.
Analysis of slides is described below.
Analysis of Lumbar DRG
L3, L4, and L5 DRG sections were analyzed for the quadriceps in vivo
rhodamine muscle injection experiments, and L4, L5, and L6 DRG sections
were analyzed for the ex vivo sciatic nerve backfill experiments. Slides were
analyzed using an Olympus BX51 Epi-fluorescence microscope and Olympus
cellSense Software. Pictures of DRGs were taken in both the FITC (green)
and TRITC (red) channels and combined channels. Three different types of
cells were recorded in each DRG: parvalbumin-expressing (PV+) cells,
Rhodamine expressing cells (Rhod+), and double-positive cells (PV+/Rhod+).
PV+ cells fluoresced green and were counted as positive if the cells were
bright green, significantly above the background. Rhod+ cells fluoresced
bright red, and cells were considered positive if they fluoresced in the red
channel above the background. Double positive cells express both PV and
Rhodamine, and the cells fluoresce green and red significantly above the
background.
The number of cells was counted in each labeled DRG (the DRGs that
were ipsilateral to the nerve/tissue labeled with the rhodamine dye) using
ImageJ software and Cell Counter plug-in. The amount of PV+, Rhod+, and
double-labeled cells were recorded in Excel. To accurately assess each cell
18

type’s distribution, the total number of PV+, Rhod+, and double-labeled cells
in each DRG (and across all animals) was counted and compared to the
percent of total labeled cells in that specific DRG. The number of each cell
type was averaged between animals and compared to the total number of cells.
Example images of the L4, L5, and L6 DRGs from the sciatic nerve backfill
experiments and images of the L3, L4, and L5 DRGs from the in vivo
rhodamine muscle injection experiments were obtained using an Olympus
FV1000 confocal microscope. Images were then analyzed using Fluoview
software (Olympus FV10-ASW Version 4.2 B).
Analysis of Quadriceps Muscle
Slides were initially analyzed using an Olympus BX51 Epi-fluorescence
microscope to record the location and number of each proprioceptor afferents
(MSs and GTOs) on each section. Muscle spindles were identified by
distinguishing morphological characteristics, specifically the annulospiral
structures around muscle fibers and flower-spray morphology. GTO afferents
were found at the myotendinous junction and identified by their highly
branched endings. More detailed images of the sensory neuron afferent were
acquired using an Olympus FV1000 confocal microscope (10X and 20X
objectives used). MS and GTO afferent images were analyzed using Fluoview
software (Olympus FV10-ASW Version 4.2B). Muscle spindle afferents were
analyzed based on three characteristics: if they were double-labeled (the
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muscle spindle afferent appears in both Alexa 488 channel and Cy3 channel),
if they were located in an area where the surrounding muscle is labeled with
the rhodamine dye, and if the intrafusal muscle fibers the MS was wrapped
around fluoresced red (signaling that it had taken up the rhodamine dye). GTO
afferents were analyzed based on the following characteristics: if the GTO
was double-labeled, meaning it fluoresced in the Alexa488 channel and the
Cy3 channel, and if the GTO was located net to or near muscle fibers that had
taken up the rhodamine dye and fluoresced red.
To assess the distribution of rhodamine dye and the association of MS
afferents with the dye, the percent of MSs associated with Rhod+ muscle
fibers was quantified and compared to the percent of MSs located in an area
where the surrounding muscle fibers had taken up the dye. Mouse 1, mouse 2,
and mouse 3 were compared in the ex vivo rhodamine muscle injection
experiments, and mouse 6B and mouse 6A were compared in the in vivo
rhodamine muscle injection experiments.
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III.

Results

Ex Vivo Rhodamine Muscle Injections
Initial microscopy analysis showed an even and thorough distribution of
rhodamine dye among the muscle fibers of the rectus femoris muscle, both right and left.
There were three mice used: one P6 (labeled mouse 1), one P5 (labeled mouse 2), and
one P3 (labeled mouse 3). Table 1 displays a summary of data from mouse 1, mouse 2,
and mouse 3 analyzed to confirm the success of the ex vivo rhodamine injections into the
quadriceps muscle. Since no muscle spindles were truly double-labeled (fluorescing in
both the vGLUT1 channel and rhodamine channel equally), the quality of rhodamine dye
distribution in the muscle and the association of proprioceptive afferents (MSs and
GTOs) was quantified in two different ways: whether the proprioceptive afferent (for
muscle spindles and Golgi tendon organs) were located in an area where the surrounding
muscle was labeled with rhodamine, and if the proprioceptive afferent (muscle spindles
only) was associated with a red muscle fiber.
For mouse 1 there were 10 slides analyzes, and of those slides, 64 sections were
analyzed. There was a total of 10 sections that contained proprioceptive structures (either
MS or GTO afferents). Overall, mouse 1 had 14 MS afferents and no GTO afferents. Of
the 14 total MS afferents analyzed, 11 were wrapped around a muscle fiber labeled with
rhodamine dye (78.6%), and 14 were located in an area where the surrounding muscle
was dyed with rhodamine (100%).
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Mouse 2 had 6 slides analyzed with a total of 24 sections, and of those, 10
sections contained proprioceptive structures (MSs or GTOs). A total of 9 muscle spindle
afferents and 6 GTO afferents were identified. Of the muscle spindles analyzed, 8 of
them were associated with a rhodamine-dyed fiber (88.9%), and 8 of them resided in an
area where the surrounding muscle fiber was rhodamine-labeled (88.9%). The muscle
sections obtained from Mouse 2 displayed 6 GTO afferents, and of those, only 1 was
located near muscle fibers that were rhodamine-labeled (approximately 16.67%).
Of the three mice analyzed, Mouse 3 had the most proprioceptive afferents, with 5
GTO afferents and 22 MS afferents visible. Of the muscle spindles examined, 18 of the
22 were associated with a rhodamine-labeled muscle fiber (82%), and all 22 spindles
were located in an area where the surrounding muscle had an even distribution of
rhodamine dye (100%). Contrastingly, only 40% of GTO afferents (2 out of 5) were
located near muscle fibers labeled with rhodamine dye.
In summary, a total number of 45 muscle spindles and 11 Golgi tendon organs
were analyzed. Of the muscle spindles examined, 37 of them (82.2%) were wrapped
around a muscle fiber that fluoresced red, confirming the uptake of rhodamine dye in that
fiber (Figure 2). Although not every MS analyzed was associated with a red muscle fiber
(8 were not), almost all muscle spindles (44 spindles; 98% of all spindles) were in an area
of muscle where there was an even distribution of rhodamine dye in the surrounding
muscle (Figure 2). These results indicate that the ex vivo rhodamine muscle injections
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were only partly successful. Even though the rhodamine dye showed an even distribution
in the rectus femoris muscle, the muscle spindles were not double-labeled and therefore
did not take up the rhodamine dye. However, no GTO afferents were double-labeled, and
only a small percentage of them were located near rhodamine dyed tissues.
Ex Vivo Sciatic Nerve Backfills
Another goal of this project was to confirm the transport of rhodamine dye from
proprioceptive nerve afferents to the supporting DRGs. Fire-polished micropipettes were
suctioned around sciatic nerves in the ex vivo mouse preparation procedure previously
mentioned, and rhodamine dye was backfilled into the pipette on top of the open end of
the sciatic nerve. To assess the successful uptake of the rhodamine dye, specifically by
proprioceptive afferents, immunohistochemistry was utilized to label PV+ cells.
Parvalbumin (PV) is a well-known molecular marker for proprioceptive neurons in
DRGs, specifically MS and GTO sensory neurons (Arber et al., 2000).
Immunohistochemistry was also used to label Rhod+ cells in the DRG, afferents that took
up the rhodamine dye from the sciatic nerve. PV+ cells in the DRG are proprioceptor
afferents that project to the sciatic nerve, and these cells fluoresced green. Cells that
fluoresced red were cells that expressed rhodamine (Rhod+); therefore, cells that only
fluoresced green (PV+ cells) were proprioceptive neurons that did not originate from the
sciatic nerve and therefore did not take up the rhodamine dye. Rhod+ cells in the DRG
(cells that fluoresced only red) are neurons that originate in the sciatic nerve that are not
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proprioceptors. Double-labeled cells that fluoresced both red and green (PV+/Rhod+) are
proprioceptive neurons that originate in the sciatic nerve and took up the rhodamine dye.
To assess the successful transport of the rhodamine dye by proprioceptive sensory
neurons, the number of PV+, Rhod+, and double-labeled cells were counted in the L4,
L5, and L6 DRG (Table 2). For this experiment, four mice were used (mouse 1, mouse 2,
mouse3, and mouse 4). On average, the L4 DRG exhibited 56.67 ± 49.97 PV+ cells, 3.33
± 5.77 Rhod+ cells, and 23.33 ± 32.62 double-labeled (Figure 7C). Mouse 1 only had 6
labeled cells, and mouse 3 did not have any visible L4 DRGs (Table 2). The majority of
labeled cells in the L4 DRG were proprioceptors that did not originate from the sciatic
nerve, with 68% of cells being PV+ cells. Rhod+ cells only represented 4% of the total
population of labeled cells, and 28% of labeled cells were double-labeled (Figure 7B).
The L4 DRG had the least number of labeled cells, with the majority of labeled cells
being non-sciatic proprioceptors (PV+) and sciatic proprioceptors (double-labeled cells).
The L5 DRG had considerably more double-labeled cells, with 59.08% of labeled
cells displaying both red and green fluorescence and an average number of 95 ±120.26
double-labeled cells. (Figure 8A). A total of 400 PV+/Rhod+ cells were observed across
four animals and 14 sections (Table 2). On average, there were 14.50 ± 10.79 Rhod+
cells and 54.75 ± 48.36 PV+ cells in the L5 DRG. Of the proprioceptors labeled (cells
labeled by PV) in the L5 DRG, the majority of cells (64.6%) project to the sciatic nerve.
The remaining proprioceptors (35.4%) project to other nerves and only fluoresce green
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(PV+). From this data, it can be concluded that the majority of PV+ proprioceptors
projecting to the sciatic nerve (PV+/Rhod+) originate in the L5 DRG, but there is also a
small population of Rhod+ cells and a considerable amount of PV+ cells (Figure 10).
The L6 DRG exhibited an average of 38.73 ± 27.03 PV+ cells, 7.50 ± 15 Rhod+
cells, and 41.75 ± 54.91 double-labeled cells (Figure 9C). There were almost equal
amounts of PV+ and double-labeled cells, with 155 cells and 167 cells, respectively
(Figure 9A and 9B). On average, the L6 DRG had 7.5 ± 15 Rhod+ cells, cells that project
to the sciatic nerve but are not proprioceptive neurons (Figure 9C). The L6 DRG showed,
on average, more labeled cells than the L4 DRG but less labeled cells than the L5 DRG
(Figure 10).
These results indicate that proprioceptive nerve afferents can transport rhodamine
dye to the DRG and effectively labeling pSNs in the mouse DRGs. Overall, the majority
of rhodamine labeled proprioceptive afferents that project to the sciatic nerve were
located in the L5 DRG (Figure 10). The L5 DRG contained the most labeled cells, with
the L6 DRG having less and the L4 DRG having the least number of labeled cells. Even
though the experiments were successful, there was considerable variability between
animals, contributing to large standard deviation values. More accurate data could be
obtained by adding additional trials.
In Vivo Rhodamine Muscle Injections
A. Muscle Analysis
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Initial analysis of MS afferents showed an even and complete distribution of the
rhodamine dye in the rectus femoris muscle of both mouse 6A and mouse 6B, mainly in
the belly of the muscle where the MSs are located (Figure 11). Of the MS afferent
observed, 91.3% of them in mouse 6B and 77.78% were associated with red muscle
fibers that took up the rhodamine dye (Figure 13). Further analysis using confocal
microscopy revealed that 69.57% of MSs imaged in mouse 6B and 66.67% of MSs
imaged in mouse 6B were located in an area with thorough rhodamine distribution.
39.13% of muscle spindles in Mouse 6B were double-labeled, and one-third of MSs
(33.33%) in mouse 6A were double-labeled. Of all three categories analyzed, mouse 6A
had slightly fewer double-labeled muscle spindles and less rhodamine dye distribution
than mouse 6B (Figure 13). This could be partially due to the differences in survival
times, as mouse 6A survived for 48 hours post injection and mouse 6B survived for 24
hours post-injection. To confirm this, however, there would need to be a larger sample
size from both groups.
Unfortunately, only 5 GTOs were able to be identified between mouse 6A and
mouse 6B. Most of the GTOs imaged were not located near the rhodamine dye (Figure
12). None of the 3 GTOs imaged from mouse 6A or the 2 GTOs imaged from mouse 6B
were double-labeled. Only 1 GTO (from mouse 6A) was located in an area where the
muscle had taken up the rhodamine dye. While the sample size is small, this data shows
that GTOs are likely not labeled by the rhodamine dye.
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B. DRG Analysis
To better assess the effectiveness of the rhodamine dye labeling proprioceptive
afferents in the DRG, the L3, L4, and L5 DRG on the ipsilateral side (right side) of the
injected muscle were analyzed. Unfortunately, both mouse 6A and mouse 6B
preparations did not yield many visible cells in the DRGs. However, some identifiable
cells were present in the L3, L4, and L5 DRGs (Figure 15). The L3 DRG in mouse 6B
displayed 25 PV+ cells, 1 Rhod+ cell, and 41 PV+/Rhod+ (double-labeled) cells, while
mouse 6A only had 9 PV+ cells, no Rhod+ cells and 5 double-labeled cells in the L3
DRG. On average, the L3 DRG exhibited 17 ± 11.31 PV+ cells, 0.5 ± 0.71 Rhod+ cells,
and 23 ± 25.45 double-labeled cells (Figure 18 C).
In mouse 6B, there were fewer labeled cells in the L4 DRG than in the L3 DRG;
however, in mouse 6A there were more labeled cells in the L4 DRG than in the L3 DRG
(Figure 21). The L4 DRGs varied in the number of each cell types depending on the
mouse (6B vs. 6A). The L4 DRG in mouse 6B displayed 23 PV+ cells, 1 Rhod+ cell, and
19 double-labeled cells (Figure 19A). Conversely, mouse 6A had 32 PV+ cells, 1 Rhod+
cell, and 6 double-labeled cells (Figure 19A). On average, the L4 DRG contained 27.5 ±
6.36 PV+ cells, 1 ± 0 Rhod+ cells, 12.5 ± 9.19 double-labeled cells, and 41 ± 2.83 total
labeled cells (Figure 19C). Compared to the L4 DRGs in the ex vivo sciatic nerve
backfill, the L4 DRGs from the in vivo rhodamine muscle injection experiments
displayed fewer labeled cells. On average, the L4 DRGs from the ex vivo experiments
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displayed a total of 83.33 ± 67.34 labeled cells; and the L4 DRGs from the in vivo
experiments had an average of 41 ± 2.83 labeled cells. However, it is essential to note
that the ex vivo experiments labeled cells from the sciatic nerve and the in vivo
experiments labeled cells originating in the rectus femoris muscle and projecting to the
spinal cord via the femoral nerve, so there are various elements to consider when
comparing the two.
The L5 DRG in both mouse 6B and mouse 6A displayed very few labeled cells.
Despite this, some double-labeled cells were present in mouse 6A and 6B, and one
Rhod+ cell in the L5 DRG of mouse 6A (Figure 20A). Mouse 6B had 14 PV+ cells and 8
double-labeled cells, while mouse 6A exhibited 12 PV+ cells, no Rhod+ cells, and 10
double-labeled cells (Figure 20A). The L5 DRG had an average of 13 ± 1.41 PV+ cells,
no Rhod+ cells, and 9 ± 1.41 double-labeled cells (Figure 20C). Similar to the L4 DRGs,
the L5 DRGs from the in vivo rhodamine muscle injection experiments exhibited fewer
cells than the L5 DRGs from the ex vivo sciatic nerve backfill experiments. The L5 DRGs
from the ex vivo experiments had an average of 88 ± 79.27 total labeled cells, while the
L5 DRGs from the in vivo experiments had an average of 22.0 ± 0 labeled cells.
Mouse 6B, which had a survival time of 24 hours post-surgery, displayed more
labeled cells than mouse 6A, which had a survival time of 48 hours. Fluorescence
microscopy showed that mouse 6B had a total of 150 labeled cells consisting of 62 PV+
cells, 2 Rhod+ cells, and 68 double-positive cells, with the majority of them (67 cells)
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residing in the L3 DRG (Figure 21A). Mouse 6A had 75 labeled cells comprising of 53
PV+ cells, 1 Rhod+ cell, and 21 double-labeled cells, where the L4 DRG had the most
labeled cells (39 cells) (Figure 21B). From this data, it can be concluded that the mouse
6B preparation was more successful at labeling cells in the DRGs than the mouse 6A
preparation. Due to the limitation of the small sample size (n=1 in each group), no
confident comparison can be made between the two post-surgery survival times.
.
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Percent of Muscle Spindles Associated with Rhodamine Dye Distribution
# of MSs
doublelabeled

Mouse 1
Mouse 2
Mouse 3
Average

0.00
0.00
0.00
0.00

# of MSs with Assocaiated
Fiber Red

# of MSs with
Total Number
% of MSs with
Surrounding Muscle Red
of MSs
Associated Fiber Red

11.00
8.00
18.00
12.33

14.00
8.00
22.00
14.66

14.00
9.00
22.00
15.00

0.79
0.89
0.82
0.83

% of MSs with
Surrounding
Muscle Red

1.00
0.89
1.00
0.96

Golgi Tendon Organ Association with Rhodamine Dye
# of GTOs
doublelabeled

Mouse 1
Mouse 2
Mouse 3
Average

0.00
0.00
0.00
0.00

GTOs Located Near Rhodamine Dyed
Tissue

Total number of GTOs

% of GTOs Near Rhodamine Dye

0.00
1.00
2.00
2.33

0.00
6.00
5.00
3.66

0.00
0.17
0.40
0.19

Table 1: Ex Vivo Muscle Injection: Rhodamine Distribution in Relation to MS and GTO
Location. Between mouse 1, mouse 2, and mouse 3, there was an average of 15 muscle
spindles per mouse, and an average of 83% of those was associated with a rhodaminedyed (red) fiber, and 96% of them were located in an area where the surrounding muscle.
Each animal had an average of 1 GTO imaged, and on average, 19% of GTOs are located
in an area where Rhodamine dye is present in the surrounding tissue.
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Analysis of Ex Vivo Sciatic Backfill DRG: L4, L5, and L6

Mouse 1 1-A
Mouse 1 2-A
Mouse 1 2-A
Mouse 1 2-A
Mouse 2 1-A
Mouse 2 1-A
Mouse 2 1-A
Mouse 2 1-A
Mouse 2 1-A
Mouse 2 1-A

1
1
1
1
5
7
8
5
7
8

L6
L4
L5
L6
L4
L4
L4
L5
L5
L5

7
2
4
14
18
17
9
27
10
17

0
0
6
0
0
0
0
2
2
1

PV+/Rhod+
Cells (DoubleLabeled)
8
4
31
12
14
7
15
36
22
27

Mouse 2 1-A
Mouse 2 1-A
Mouse 2 2-A
Mouse 2 2-A
Mouse 2 2-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A

5
7
1
1
2
1
2
3
4
5

L6
L6
L4
L4
L5
L5
L5
L5
L5
L5

19
7
11
13
8
17
21
31
23
14

0
0
0
0
0
5
0
3
12
6

2
0
0
25
6
44
64
49
37
42

21
7
11
38
14
66
85
83
72
62

Mouse 3 1-A

6

L5

12

1

35

48

Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 3 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-A
Mouse 4 1-B
Mouse 4 1-B
Mouse 4 1-B
TOTAL

1
2
3
4
5
4
5
6
6
6
7
7
8
3
4
5

L6
L6
L6
L6
L6
L4
L5
L4
L5
L6
L5
L6
L6
L4
L4
L4

15
14
18
15
17
31
8
22
5
11
22
9
9
12
32
3
544

0
0
0
0
0
2
8
5
6
11
6
5
14
0
1
2
98

34
28
24
19
18
0
4
0
0
11
3
5
6
0
4
1
637

49
42
42
34
35
33
20
27
11
33
31
19
29
12
37
6
1279

Slide

Section Location

PV+ Cells
(Green Cells)

Rhod+ Cells
(Red Cells)

Total
Number
of cells
15
6
41
26
32
24
24
65
34
45

Table 2: Ex Vivo Sciatic Nerve Backfills: Number of Cells Labeled. Distribution of cells
in the L4, L5, and L6 DRGs across mouse 1, mouse 2, mouse 3, and mouse 4.
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Number of Cells in L4, L5, and L6 DRG
Analysis of Labeled Cells in L4 DRG
PV+ Cells
Rhod+ Cells

# of Cells
% of Total Cells
170
68.00%
10

4.00%

PV+/Rhod+ Cells
70
28.00%
Analysis of Labeled Cells in L5 DRG
# of Cells
% of Total Cells
PV+ Cells
219
32.35%
Rhod+ Cells
58
8.57%
PV+/Rhod+ Cells
400
59.08%
Analysis of Labeled Cells in L6 DRG
# of Cells
% of Total Cells
PV+ Cells
155
44.03%
Rhod+ Cells
30
8.52%
PV+/Rhod+ Cells

167

47.44%

Table 3: Ex Vivo Sciatic Nerve Backfills: Individual Lumbar DRG Analysis. Comparison
of the number and distribution of labeled cells in the L4, L5, and L6 DRG.
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Average Number of Cells in L4, L5, and L6 DRG

Animal #
Mouse 1
Mouse 2
Mouse 4
Average # of
Cells

Animal #
Mouse 1
Mouse 2
Mouse 3
Mouse 4
Average # of
Cells

Animal #
Mouse 1
Mouse 2
Mouse 3
Mouse 4
Average # of
Cells

Average # of Cells in L4 DRG
PV+/Rhod+
PV+ (Green
Rhod+ (Red
(Double
Total Number
Cells)
Cells)
Labeled Cells) of cells
2
0
4
6
68
0
61
129
100
10
5
115
56.67
3.33
23.33
83.33
Average # of Cells in L5 DRG
PV+/Rhod+
PV+ (Green
Rhod+ (Red
(Double
Total Number
Cells)
Cells)
Labeled Cells) of cells
4
6
31
41
62
5
71
138
118
27
271
416
35
20
7
62
54.75
14.50
95.00
164.25
Average # of Cells in L6 DRG
PV+/Rhod+
PV+ (Green
Rhod+ (Red
(Double
Total Number
Cells)
Cells)
Labeled Cells) of cells
21
0
20
41
26
0
2
28
79
0
123
202
29
30
22
81
38.75

7.50

41.75

88.00

Table 4: Ex Vivo Sciatic Nerve Backfills: Average Number of Cells in L4, L5, and L6
DRGs. The total number of each cell type from mouse 1, mouse 2 mouse 3, and mouse 4
was averaged to reflect the numbers of labeled cells in the average mouse L4, L5, and L6
DRGs.
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In Vivo Rhodamine Muscle Injection: MS Afferent Analysis
Animal
Mouse 6B
Mouse 6A

Mouse 6B
Mouse 6A
Average

Number of MS with
Associated Muscle
Fiber Red

Number of MS with
Surrounding Fiber
Red

Total Number of
MS Afferents
Identified

Number of
Double Labeled
MS Afferents

21
7
Percent of MS
afferents with
Associated Fiber
Red
91.30%
77.78%
84.54%

16
6
Percent of MS
Afferents with
Surrounding Fiber
Red
69.57%
66.67%
68.12%

23
9

9
3

Percent of MS Fibers that are
Double Labeled
39.13%
33.33%
36.23%

In Vivo Rhodamine Muscle Injection: GTO Afferent Analysis
Animal
Mouse 6B
Mouse 6A

Mouse 6B
Mouse 6A
Average

Number of GTO
Afferents Located
Near Red Muscle
Fibers
0
1

Number of GTO
Afferents Double
Labeled

Total Number of GTO Afferents

0
0

2
3

Percent of GTO Afferents Located Near
Red Muscle Fibers

Percent of GTO Afferents Double
Labeled

0%
33.33%
16.67%

0%
0%
0%

Table 5: In Vivo Rhodamine Muscle Injection: GTO and MS Afferent analysis. In both
mouse 6A and 6B, the majority of muscle spindles imaged were associated with muscle
fibers that absorbed the rhodamine dye. However, all but one GTO imaged was not
associated with the rhodamine dye.
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Analysis of cells in Mouse 6B L3 DRG
Slide

Section

Mouse 6B 1-B
Mouse 6B 1-B
Mouse 6B 2-B
Mouse 6B 2-B
Mouse 6B 2-B
Mouse 6B 2-B
TOTAL

5
10
2
3
4
5

Location PV+ (Green Cells) Rhod+ (Red Cells)
L3
L3
L3
L3
L3
L3

0
4
7
8
5
1
25

0
0
0
1
0
0
1

PV+/Rhod+ (Double Total Number of
Labeled)
cells
7
7
6
10
10
17
9
18
6
11
3
4
41
67

Analysis of cells in Mouse 6B L4 DRG
Slide

Section

Mouse 6B 1-B
Mouse 6B 2-B
Mouse 6B 2-B
Mouse 6B 2-B
Mouse 6B 2-B
TOTAL

10
2
3
4
5

Location PV+ (Green Cells) Rhod+ (Red Cells)
L4
L4
L4
L4
L4

0
3
6
13
1
23

0
0
0
0
1
1

PV+/Rhod+ (Double Total Number of
Labeled)
cells
5
5
3
6
4
10
4
17
3
5
19
43

Analysis of cells in Mouse 6B L5 DRG
Slide

Section

Mouse 6B 1-B
Mouse 6B 2-B
Mouse 6B 2-B
TOTAL

10
4
11

Location PV+ (Green Cells) Rhod+ (Red Cells)
L5
L5
L5

7
3
4
14

0
0
0
0

PV+/Rhod+ (Double Total Number of
Labeled)
cells
4
11
4
7
0
4
8
22

Total Cell Count for Mouse 6B
Animal
Mouse 6B

PV+
(Green
Cells)
62

Rhod+ (Red Cells)

PV+/Rhod+
(Double Labeled)

Total Number of cells

2

68

132

Table 6: In Vivo Rhodamine Muscle Injection: Cell Count for Mouse 6B. Distribution of
labeled cells across L3, L4, and L5 DRGs.
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Analysis of cells in Mouse 6A L3 DRG
Location PV+ (Green Cells) Rhod+ (Red Cells)

PV+/Rhod+ (Double Total Number of
Labeled)
cells
1
2
2
7
0
0
2
4

Slide

Section

Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B

1
2
3
4

L3
L3
L3
L3

1
5
0
2

0
0
0
0

Mouse 6A 2-B

5

L3

1

0

0

1

9

0

5

14

TOTAL

Analysis of cells in Mouse 6A L4 DRG
Slide

Section

Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
TOTAL

1
2
3
4
5

Location PV+ (Green Cells) Rhod+ (Red Cells)
L4
L4
L4
L4
L4

8
4
11
3
6
32

0
0
0
1
0
1

PV+/Rhod+ (Double Total Number of
Labeled)
cells
0
8
1
5
0
11
1
5
4
10
6
39

Analysis of cells in Mouse 6A L5 DRG
Slide

Section

Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
Mouse 6A 2-B
TOTAL

1
2
3
4
5

Location PV+ (Green Cells) Rhod+ (Red Cells)
L5
L5
L5
L5
L5

3
0
5
1
3
12

0
0
0
0
0
0

PV+/Rhod+ (Double Total Number of
Labeled)
cells
0
3
2
2
1
6
7
8
0
3
10
22

Total Cell Count for Mouse 6A
Animal
Mouse 6A

PV+
(Green
Cells)
53

Rhod+ (Red Cells)

PV+/Rhod+
(Double Labeled)

Total Number of cells

1

21

75

Table 7: In Vivo Rhodamine Muscle Injection: Cell Count for Mouse 6A. Distribution of
labeled cells across L3, L4, and L5 DRGs.
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Rhodamine vGlut1

A

B

Rhodamine vGlut1

B

Figure 1: Ex Vivo Rhodamine Muscle Injection: MS vs GTO Confocal Images. Confocal
images of muscle spindles (top) and Golgi tendon organs (bottom). (A) Longitudinal
section through a muscle spindle labeled with rhodamine (red) and vGlut1 (green).
Muscle fiber associated with the muscle spindle nerve terminal is labeled with the
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rhodamine dye. The surrounding intrafusal muscle fibers display bright red rhodamine
dye. (B) Golgi tendon organ sectioned longitudinally is labeled with vGlut1 (green). GTO
is wrapped around a muscle fiber that lacks rhodamine dye (red). The surrounding muscle
is inconsistently labeled red.
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Figure 2: Ex Vivo Muscle Injection: MS Association with Rhodamine Dye Distribution.
Muscle spindle nerve endings are associated with the area of the muscle affected by the
rhodamine dye. (A) Percent of muscle spindles that are associated with a rhodaminelabeled muscle fiber. In mouse 1, 78.6% of muscle spindles are associated with a
rhodamine-labeled muscle fiber, and 88.9% of muscle spindles in mouse 2 are associated
with a rhodamine-labeled muscle fiber. The percent of muscle spindles in mouse 3
associated with a rhodamine-labeled muscle fiber is 81.8%, and the average between all 3
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animals is 83.1%. (B) Percent of muscle spindles located in an area where the
surrounding muscle is dyed red. All the muscle spindles in mouse 1 and mouse 3 (100%)
were in an area where the surrounding muscle is rhodamine labeled. 89% of spindles
were surrounded by red muscle fibers in mouse 2, and the average between the three mice
is 96%.
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Figure 3: Ex Vivo Rhodamine Muscle Injection: Percent of GTO Afferents Association
with Rhodamine Dye. Mouse 1 did not display any GTO afferents. Mouse 2 had 1 GTO
(out of 6 total) that was located where the surrounding tissue had taken up the rhodamine
dye (17%). 2 out of 5 GTO afferents in Mouse 3 were located near tissue with rhodamine
dye (40%). On average, only 19% of identified GTOs were located near tissues with
rhodamine dye.
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Figure 4: Ex Vivo Sciatic Nerve Backfills: Confocal images of Fluorescence L4 DRG
PV/Rhodamine Labeled. (A) Alexa488 (green) channel only shows PV+ cells. There are
many PV+ cells (green). (B) Cy3 (red) channel only shows Rhod+ cells. There are no
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visible Rhod+ only cells. (C) Merged channels of Alexa488 and Cy3 show the doublelabeled cells (PV+/Rhod+). There are approximately 70 double-labeled cells
(PV+/Rhod+). Scale bar = 120 μm.
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Figure 5: Ex Vivo Sciatic Nerve Backfills: Confocal images of Fluorescence L5 DRG
PV/Rhodamine Labeled. (A) Alexa488 (green) channel only shows PV+ cells. (B) Cy3
(red) channel only shows Rhod+ cells. (C) Merged channels of Alexa488 and Cy3 show
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the double-labeled cells (PV+/Rhod+). The L5 DRG has a more diverse profile of cells
with approximately 184 green cells, 38 red cells, and 393 double-labeled cells. Scale bar
= 120 μm.
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Figure 6: Ex Vivo Sciatic Nerve Backfills: Confocal images of Fluorescence L6 DRG
PV/Rhodamine Labeled. (A) Alexa488 (green) channel only shows PV+ cells. There are
many PV+ cells (green), particularly around the periphery of the DRG. (B) Cy3 (red)
channel only shows Rhod+ cells. There are no visible Rhod+ only cells. (C) Merged
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channels of Alexa488 and Cy3 show the double-labeled cells (PV+/Rhod+). There are
many PV+ cells (green) and one double-labeled cell (PV+/Rhod+). Scale bar = 120 μm.
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Figure 7: Ex Vivo Sciatic Nerve Backfills: Analysis of the L4 DRG. (A) The total
number of cells at the L4 DRG level across animals 1, 2, 3, and 4. A total number of 170
PV+ cells, 10 Rhod+ Cells, and 70 PV+/Rhod+ (double-labeled) cells were analyzed. (B)
The percent of each cell type compared to the total number of visible cells counted. 68%
of cells are PV+ cells, 28% of cells are PV+/Rhod+ (double-labeled) cells, and only 4%
of cells are Rhod+ cells. (C) The average number of each cell type in the L4 DRG
between mouse 1, mouse 2, and mouse 3. On average, 56.67 PV+ cells, 3.33 Rhod+ cells,
and 23.33 PV+/Rhod+ cells are located in the mouse DRG. The L4 DRG has an average
of 83.33 labeled cells.
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Figure 8: Ex Vivo Sciatic Nerve Backfills: Analysis of the L5 DRG. (A) The total
number of 677 cells at the L5 DRG level across animals 1, 2, 3, and 4. A total number of
219 PV+ cells, 58 Rhod+ Cells, and 400 PV+/Rhod+ (double-labeled) cells were
analyzed. (B) The percent of each cell type compared to the total number of visible cells
counted. 32.35% of cells are PV+ cells, 59.08% of cells are PV+/Rhod+ (double-labeled)
cells, and only 9% of cells are Rhod+ cells. (C) The average number of each cell type in
the L5 DRG between mouse 1, mouse 2, and mouse 3. On average, 54.75 PV+ cells, 14.5
Rhod+ cells, and 95.0 PV+/Rhod+ cells are located in the mouse DRG. The L5 DRG has
an average of 164.25 labeled cells.
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Figure 9: Ex Vivo Sciatic Nerve Backfills: Analysis of the L6 DRG. (A) The total
number of 212 cells at the L6 DRG level across animals 1, 2, 3, and 4. A total number of
155 PV+ cells, 30 Rhod+ Cells, and 167 PV+/Rhod+ (double-labeled) cells were
analyzed. (B) The percent of each cell type compared to the total number of visible cells
counted. 44.03% of cells are PV+ cells, 47.44% of cells are PV+/Rhod+ (double-labeled)
cells, and 8.52% are Rhod+ cells. (C) The average number of each cell type in the L6
DRG between mouse 1, mouse 2, and mouse 3. On average, 38.75 PV+ cells, 7.5 Rhod+
cells, and 41.75 PV+/Rhod+ cells are located in the mouse DRG. The L6 DRG has an
average of 88.0 labeled cells.
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Figure 10: Ex Vivo Sciatic Nerve Backfills: Analysis of the Average Number of Each
Cell Types in L4, L5, and L6 DRG. The L5 DRG has the most labeled cells with an
average of 54.75 PV+ cells, 14.5 Rhod+ cells, and 95 PV+/Rhod+ (double-labeled) cells.
The L4 DRG contained an average of 56.67 PV+ cells, 3.33 Rhod+ cells, and 23.33
double-labeled cells. The L6 DRG had an average of 38.75 PV+ cells, 7.5 Rhod+ cells,
and 41.75 double-labeled cells. Across all the DRGs, there was an average total of 150.17
PV+ cells, 25.33 Rhod+ cells, and 100.08 double-labeled cells.
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Figure 11: In Vivo Rhodamine Muscle Injections: Confocal Images of an MS Afferent.
(A) Alexa 488 (green) channel only shows vGLUT1 labeled tissue. The muscle spindle
afferent is visible and prominent in the green channel. (B) Cy3 (red) channel shows
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tissues that contain Rhodamine dextran dye (Rhod+). The muscle spindle morphology is
visible in this channel. (C) Combined channels (Alexa 488 and Cy3) show the MS’s
association with surrounding red muscle fibers. Scale bar = 100 μm.
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Figure 12: In Vivo Rhodamine Muscle Injections: Confocal Images of a GTO Afferent.
(A) Alexa 488 (green) channel in grayscale shows vGLUT1 labeled tissue. The GTO
afferent is visible in the green channel. (B) Cy3 (red) channel in grayscale shows tissues
that contain Rhodamine dextran dye (Rhod+). The GTO afferent is not in this channel.
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(C) Combined channels (Alexa 488 and Cy3) show the association of the GTO afferent
with surrounding tissue and the distribution of Rhodamine dye. Scale bar = 100 μm.
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Figure 13: In Vivo Rhodamine Muscle Injection: MS Afferent Association with
Rhodamine Dye. In Mouse 6B, 91.3% of MS afferents were wrapped around a red
(rhodamine dyed) muscle fiber, 69.57% of MS afferents were located in an area where
surrounding muscle fibers are red, and 39.13% of MS afferents were double-labeled. In
Mouse 6A, 77.78% of MS afferents were associated with a red muscle fiber, 66.67% of
MS afferents were located near red surrounding muscle fibers, and 33.33% of MS
afferents are double-labeeld.
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Figure 14: In Vivo Rhodamine Muscle Injection: GTO Afferent Association with
Rhodamine Dye. None of the 5 total GTO afferents imaged were double-labeled (0% for
both Mouse 6A and Mouse 6B). For Mouse 6B, no GTO afferents were located near any
red (rhodamine-dyed) tissue (0%). For Mouse 6A, one GTO afferent (33.33%) was
located near red muscle fibers.
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Figure 15: In Vivo Rhodamine Muscle Injection: Confocal Image of the L3 DRG. (A)
Grayscale of the Alexa 488 (green) channel shows PV+ cells. (B) Grayscale of the Cy3
(red) channel shows Rhod+ cells. (C) Combined channels show PV+ cells, Rhod+ cells,
and double-labeled cells. Scale bar = 120 μm.
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Figure 16: In Vivo Rhodamine Muscle Injection: Confocal Image of the L4 DRG. (A)
Grayscale of the Alexa 488 (green) channel shows PV+ cells. (B) Grayscale of the Cy3
(red) channel shows Rhod+ cells. (C) Combined channels show PV+ cells, Rhod+ cells,
and double-labeled cells. Scale bar = 120 μm.
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Figure 17: In Vivo Rhodamine Muscle Injection: Confocal Image of the L5 DRG. (A)
Grayscale of the Alexa 488 (green) channel shows PV+ cells. (B) Grayscale of the Cy3
(red) channel shows Rhod+ cells. (C) Combined channels show PV+ cells, Rhod+ cells,
and double-labeled cells. Scale bar = 120 μm.
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Figure 18: In Vivo Rhodamine Muscle Injections: Analysis of the L3 DRG. (A) Mouse
6B had total of 25 PV+ cells, 1 Rhod+ cell, and 41 PV+/Rhod+ (double-labeled) cells in
the L3 DRG. Mouse 6A displayed 9 PV+ cells, no Rhod+ cells, and 5 double-labeled
cells. (B) In Mouse 6B, PV+ cells made up 37.31% of total cells, Rhod+ cells made up
1.49 % of total cells, and double-labeled cells made up 61.19% of total cells. In Mouse
6A, PV+ cells made up 64.29% of cells and double-labeled cells made up 35.71% of the
total cell population. (C) The average number of cell types in the mouse L3 DRG.
Between Mouse 6A and 6B, there was an average of 17 PV+ cells, 0.5 Rhod+ cells, and
23 double-labeled cells in the L3 DRG.
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Figure 19: In Vivo Rhodamine Muscle Injections: Analysis of the L4 DRG. (A) Mouse
6B had total of 23 PV+ cells, 1 Rhod+ cell, and 19 PV+/Rhod+ (double-labeled) cells in
the L4 DRG. Mouse 6A displayed 32 PV+ cells, 1 Rhod+ cell, and 6 double-labeled
cells. (B) In Mouse 6B, PV+ cells made up 53.49% of the total cells, Rhod+ cells made
up 3.32% of total cells, and double-labeled cells made up 44.19% of total cells. In Mouse
6A, PV+ cells made up 82.05% of cells, Rhod+ cells made up 2.56% of cells, and
double-labeled cells made up 15.38% of the total cell population. (C) The average
number of cell types in the mouse L4 DRG. Between Mouse 6A and 6B, there was an
average of 27.50 PV+ cells, 1 Rhod+ cell, and 12.5 double-labeled cells in the L4 DRG.
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Figure 20: In Vivo Rhodamine Muscle Injections: Analysis of the L5 DRG. (A) Mouse
6B had total of 14 PV+ cells, no Rhod+ cells, and 8 PV+/Rhod+ (double-labeled) cells in
the L5 DRG. Mouse 6A displayed 12 PV+ cells, no Rhod+ cells, and 10 double-labeled
cells. (B) In Mouse 6B, PV+ cells made up 63.63% of the total cells and double-labeled
cells made up 36.36% of the total cells. In Mouse 6A, PV+ cells made up 54.54% of cells
and double-labeled cells made up 45.45% of the total cell population. (C) The average
number of cell types in the mouse L5 DRG. Between Mouse 6A and 6B, there was an
average of 13 PV+ cells, no Rhod+ cells, and 9 double-labeled cells in the L5 DRG.
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Figure 21: In Vivo Rhodamine Muscle Injection: DRG Cell Analysis for Mouse 6B and
Mouse 6A. (A) Distribution of cell types in Mouse 6B L3, L4, and L5 DRGs. The L3
DRG in mouse 6B had 25 PV+ cells, 1 Rhod+ cell, and 41 double-labeled cells. The L4
DRG in mouse 6B had 23 PV+ cells, 1 Rhod+ cell, and 19 double-labeled cells. The L5
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DRG in mouse 6B had the least number of cells, with no Rhod+ cells, 14 PV+ cells, and
8 double-labeled cells. (B) Distribution of cells in mouse 6A L3, L4, and L5 DRGs. The
L3 DRG in mouse 6A had 9 PV+ cells, no Rhod+ cells, and 5 double-labeled cells. The
L4 DRG had more cells, with 32 PV+ cells, 1 Rhod+ cell, and 6 double-labeled cells.
Mouse 6A’s L5 DRG exhibited 12 PV+ cells, no Rhod+ cells, and 10 double-labeled
cells.
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IV.

Discussion

Ex Vivo Rhodamine Muscle Injections
Confocal microscopy of the rectus femoris muscle revealed that no proprioceptive
structures (MSs or GTOs) were double labeled using the ex vivo animal preparation.
However, a high percentage of muscle spindles images were associated with rhodaminelabeled muscle fibers (Figure 2A) and approximately 96% muscle spindles imaged had
surrounding muscle labeled with the rhodamine dye (Figure 2B). This data indicated that
it is possible for muscle spindles to take up rhodamine dye when it is injected directly
into the target muscle. This lack of double labeling despite thorough distribution of the
rhodamine dye could be due to complications in the ex vivo animal preparation, such as
cells not receiving proper oxygenation. Consistent with previous studies, all GTOs
imaged were located along the myotendinous boundaries of the muscle, where little to no
rhodamine dye was injected (Schoultz and J.E., 1972). On average, only 19% of GTOs
were located near muscle labeled with the rhodamine dye, and none were double labeled
(Figure 3). Due to their differential location, MS afferents are likely to absorb the
rhodamine dye when injected, but GTO afferents are not (Figure 1).
Ex Vivo Sciatic Backfills
To test the ability of sensory neurons to absorb and transport rhodamine dye to their
cell bodies in the DRGs, rhodamine dye was backfilled into a fire-polished micropipette
suctioned around the sciatic nerve, as previously described. The supporting DRGs (L4,
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L5, and L6) were analyzed to quantify the number of proprioceptive afferents (PV+
cells), neurons projecting to the sciatic nerve (Rhod+ cells), and proprioceptive afferents
that project to the sciatic nerve (double-labeled cells).
All three types of cells (PV+, Rhod+, and double-labeled) were observed in the L4
(Figure 4), L5 (Figure 5), and L6 (Figure 6) DRGs on the ipsilateral side of labeled
sciatic nerve. This pattern of labeling suggests the successful transport of the rhodamine
dye from the sciatic nerve to the associated DRGs. Figures 7 through 9 show the
distribution and location of each labeled cell in the L4 through L6 DRGs. The L4 DRG
contained mostly proprioceptive sensory neurons that did not project to the sciatic nerve,
but also displayed non-pSN and pSN afferents that did project to the sciatic nerve.
Double-labeled cells (pSNs that project to the sciatic nerve) were most abundant in the
L5 DRG, but these cells were visible in the L4 through L6 DRGs (Figure 10). As shown
in Figure 8 and 9, the L5 and L6 DRG exhibited labeled cells from all three categories
(PV+, Rhod+, and PV+/Rhod+), but it is important to note that the majority of labeled
cells in the L5 DRG are double labeled, indicating that most of proprioceptive sensory
afferents in the L5 DRG project to the sciatic nerve. As shown in Figure 10, the L4, L5,
and L6 DRGs exhibited cells labeled by the rhodamine dye and parvalbumin, which
confirm the successful transport of the rhodamine dye to the supporting DRGs.
In Vivo Rhodamine Muscle Injections
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To further evaluate the ability of rhodamine dye to selectively label muscle spindle
afferents, the rhodamine dye was injected into the rectus femoris muscle in vivo as
previously described. As shown in Figure 11, the muscle spindle is visible in the Cy3
channel, confirming the successful uptake of rhodamine dye into the muscle spindle
afferents. Confocal analysis revealed that ~36.23% of MSs imaged were double-labeled,
however ~84.54% of MSs were associated with rhodamine-dyed intrafusal muscle fibers.
This suggests that there is room for improvement in the injection technique, particularly
in the amount of rhodamine injected. Unfortunately, there were only a few GTO afferents
identified; however, none were double-labeled and only one (an average of 16.67%) GTO
was located near rhodamine-dyed tissue. This preliminary data suggests that MS afferents
are labeled by the rhodamine dye injected into the muscle, while excluding GTO
afferents. It is important to note that this technique can only distinguish between muscle
spindle afferents (supplied by group Ia and group II endings) and Golgi tendon afferents
(supplied by group Ib endings) and cannot distinguish between group Ia and group II
endings.
Analysis of the L3, L4, and L5 DRGs, the DRGs that project to the femoral and
quadriceps nerves revealed the successful transmission of the rhodamine dye from
proprioceptive endings in the muscle to the DRGs. Three types of cells were quantified:
proprioceptive cells that were not labeled by the rhodamine dye (PV+ cells),
proprioceptive cells that project to the rectus femoris muscle and did transport the
rhodamine dye (double-labeled cells), and cells that did transport the rhodamine dye but
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are not proprioceptive afferents (Rhod+ cells). On average, the L3 and L4 DRGs had
approximately the same number of labeled cells (~40.5 cells in the L3 and ~41 cells in
the L4 DRG); however, the L4 DRG contained more PV+ cells and the L3 DRG
contained more double-labeled cells. As shown in Figure 21, the in vivo rhodamine
muscle injection was successful at labeling afferents that originate in the L3, L4, and L5
DRGs. From the lack of Rhod+ labeled cells (neurons that took up the rhodamine dye but
are not proprioceptors), it can be concluded that the rhodamine injections favorably label
proprioceptive afferents. However, few Rhod+ cells were observed in miniscule amounts
compared to PV+ and double-labeled cells. Due to the small sample size, the comparison
between survival times is inconclusive, and more studies are needed to further example
the optimal survival time for this method.
While the ex vivo rhodamine muscle injection experiments did not produce any
double-labeled proprioceptive afferents, it did show thorough and even rhodamine
distribution within the rectus femoris muscle, which primarily surrounded MS afferents
and not GTO afferents. This technique has the possibility to be successful; however,
improvements in tissue oxygenation and survival are required. The ex vivo sciatic nerve
backfill experiments displayed the capability of selectively labeling proprioceptive
afferents in the DRGs of mice with the use of rhodamine dye. Finally, the in vivo
rhodamine muscle injection experiments confirmed that by injecting rhodamine dye
directly into the live rectus femoris muscle, it is possible to selectively label MS afferents
in the corresponding DRGs. This technique has the potential to be used in ex vivo and in
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vivo animal preparations and electrophysiology experiments where identifying and
labeling proprioceptive subtypes is necessary.
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